Authors:
ZAMBETTI M
QUATTRONE P
VERDERIO P
ORIANA S
VALAGUSSA P
TERENZIANI M
ZUCALI R
BONADONNA G
Citation: M. Zambetti et al., 5-YEAR RESULTS OF COMBINED-MODALITY APPROACH IN LOCALLY ADVANCED BREAST-CANCER (LABC) - ANALYSIS OF PROGNOSTIC FACTORS, European journal of cancer, 34, 1998, pp. 70-70
Authors:
BONADONNA G
VALAGUSSA P
BRAMBILLA C
FERRARI L
MOLITERNI A
TERENZIANI M
ZAMBETTI M
Citation: G. Bonadonna et al., PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER - 8-YEAR EXPERIENCE ATTHE MILAN-CANCER-INSTITUTE, Journal of clinical oncology, 16(1), 1998, pp. 93-100
Authors:
BREGNI M
SIENA S
DINICOLA M
ZAMBETTI M
MATTEUCCI P
BONADONNA G
GIANNI AM
Citation: M. Bregni et al., DOSE-RESPONSE EFFECT OF CYCLOPHOSPHAMIDE IN LOCALLY ADVANCED METASTATIC BREAST-CANCER/, Bone marrow transplantation, 21, 1998, pp. 210-210
Authors:
GIANNI AM
SIENA S
BREGNI M
DINICOLA M
OREFICE S
CUSUMANO F
SALVADORI B
LUINI A
GRECO M
ZUCALI R
RILKE F
ZAMBETTI M
VALAGUSSA P
BONADONNA G
Citation: Am. Gianni et al., EFFICACY, TOXICITY, AND APPLICABILITY OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AS ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER WITH 10 OR MORE INVOLVED AXILLARY NODES - 5-YEAR RESULTS, Journal of clinical oncology, 15(6), 1997, pp. 2312-2321
Authors:
ZAMBETTI M
DEMICHELI R
DECANDIS D
ANTONELLI G
GIACOBONE A
TERENZIANI M
LAFFRANCHI A
GARBAGNATI E
BIASI S
BONADONNA G
Citation: M. Zambetti et al., 5-DAY INFUSION FLUOROURACIL PLUS VINORELBINE IV IN METASTATIC PRETREATED BREAST-CANCER PATIENTS, Breast cancer research and treatment, 44(3), 1997, pp. 255-260
Citation: M. Zambetti et al., ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL IN NODE-NEGATIVE AND ESTROGEN RECEPTOR-NEGATIVE BREAST-CANCER - UPDATED RESULTS, Annals of oncology, 7(5), 1996, pp. 481-485
Authors:
ZAMBETTI M
TERENZIANI M
BARTOLI C
VALAGUSSA P
PIOTTI P
FERRANTI C
BONADONNA G
Citation: M. Zambetti et al., INTERMEDIATE DOSES OF CYCLOPHOSPHAMIDE ALONE OR FOLLOWING ADRIAMYCIN IN ADVANCED BREAST-CANCER - A PILOT-STUDY, American journal of clinical oncology, 19(1), 1996, pp. 82-86
Authors:
TERENZIANI M
DEMICHELI R
BRAMBILLA C
FERRARI L
MOLITERNI A
ZAMBETTI M
CARACENI A
MARTINI C
BONADONNA G
Citation: M. Terenziani et al., VINORELBINE - AN ACTIVE, NON CROSS-RESISTANT DRUG IN ADVANCED BREAST-CANCER - RESULTS FROM A PHASE-II STUDY, Breast cancer research and treatment, 39(3), 1996, pp. 285-291
Citation: G. Bonadonna et al., DOXORUBICIN FOLLOWED BY CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST-CANCER - REPLY, JAMA, the journal of the American Medical Association, 274(10), 1995, pp. 796-797
Citation: G. Bonadonna et al., SEQUENTIAL OR ALTERNATING DOXORUBICIN AND CMF REGIMENS IN BREAST-CANCER WITH MORE THAN 3 POSITIVE NODES - 10-YEAR RESULTS, JAMA, the journal of the American Medical Association, 273(7), 1995, pp. 542-547
Authors:
BONADONNA G
VALAGUSSA P
MOLITERNI A
ZAMBETTI M
BRAMBILLA C
Citation: G. Bonadonna et al., CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP, The New England journal of medicine, 332(14), 1995, pp. 901-906
Authors:
DEMICHELI R
TERENZIANI M
VALAGUSSA P
MOLITERNI A
ZAMBETTI M
BONADONNA G
Citation: R. Demicheli et al., LOCAL RECURRENCES FOLLOWING MASTECTOMY - SUPPORT FOR THE CONCEPT OF TUMOR DORMANCY, Journal of the National Cancer Institute, 86(1), 1994, pp. 45-48
Authors:
VALAGUSSA P
MOLITERNI A
TERENZIANI M
ZAMBETTI M
BONADONNA G
Citation: P. Valagussa et al., 2ND MALIGNANCIES FOLLOWING CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER, Annals of oncology, 5(9), 1994, pp. 803-808
Authors:
VALAGUSSA P
ZAMBETTI M
BIASI S
MOLITERNI A
ZUCALI R
BONADONNA G
Citation: P. Valagussa et al., CARDIAC EFFECTS FOLLOWING ADJUVANT CHEMOTHERAPY AND BREAST IRRADIATION IN OPERABLE BREAST-CANCER, Annals of oncology, 5(3), 1994, pp. 209-216
Authors:
ZUCCHETTI M
ZAMBETTI M
HARTLEY JM
DINCALCI M
Citation: M. Zucchetti et al., LACK OF BONE-MARROW TOXICITY OF HIGH-DOSE CYCLOPHOSPHAMIDE ASSOCIATEDWITH INEFFICIENT DRUG-METABOLISM, Annals of oncology, 4(10), 1993, pp. 895-895